Dian Diagnostics Group's share price decline mirrors its falling EPS. Its performance has been worse than the broader market over the past year. Investors should consider other factors and warning signs before investing.

Dian Diagnostics GroupLtd's low P/S ratio is likely due to limited future growth expectations. Its underwhelming revenue outlook contributes to the low P/S, forming a barrier for the share price.

Dian Diagnostics GroupLtd's declining ROCE trend is worrying, indicating more capital investment but not higher returns or sales increase. Despite a 47% return to shareholders in the past five years, current fundamentals don't inspire future performance confidence.